Platelet transfusion is the administration of a donor platelet component of blood through a vein to a patient to temporarily increase the number of functional platelets or to help stop bleeding.
Albumin, a key plasma protein, is widely used in surgical procedures. Experience shows that albumin solutions are the "gold standard" for transfusion therapy in critical conditions caused by hypovolemia and intoxication.
For quite a long time, preserved donor blood was considered the most effective and universal treatment for hemorrhagic anemia, hypovolemic conditions, protein metabolism disorders of various etiologies, etc.
Red blood cell mass (RBC) is a component of blood consisting of red blood cells (70-80%) and plasma (20-30%) with some leukocytes and platelets (hematocrit: 65-80%). In terms of red blood cell content, one dose of RBC mass (270 ± 20 ml) is equivalent to one dose (510 ml) of blood.
Therapeutic hemapheresis includes plasmapheresis and cytapheresis, which are generally tolerated by healthy donors. However, there are numerous minor and a few significant risks.
Before starting a transfusion, it is necessary to check the container labeling and conduct compatibility tests to ensure that the component is intended for the recipient.
Whole blood transfusion improves the oxygen capacity of the blood, restores volume, clotting factors and was previously recommended for massive blood loss.
